caplacizumab

Sanofi reaps first fruit of Ablynx buyout with a European OK for its lead rare disease drug
Endpoints
Tue, 09/4/18 - 05:01 pm
Ablynx
Sanofi
Europe
caplacizumab
M&A
aTTP
Ablynx files rare blood disorder drug, raising prospect of first commercial product next year
Fierce Biotech
Tue, 02/7/17 - 10:32 am
Ablynx
caplacizumab
Europe
aTTP